Manchester Capital Management’s NeoGenomics NEO Stock Holding History

Manchester Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-142	Closed	-$2.34K	–	1193
2024 Q4	$2.34K	Hold	142	–	–	﹤0.01%	973
2024 Q3	$2.1K	Hold	142	–	–	﹤0.01%	989
2024 Q2	$1.97K	Hold	142	–	–	﹤0.01%	949
2024 Q1	$2.23K	Hold	142	–	–	﹤0.01%	820
2023 Q4	$2.3K	Hold	142	–	–	﹤0.01%	801
2023 Q3	$1.75K	Hold	142	–	–	﹤0.01%	783
2023 Q2	$2.28K	Sell	142 -26	-15%	-$428	﹤0.01%	726
2023 Q1	$2.92K	Sell	168 -131	-44%	-$1.87K	﹤0.01%	726
2022 Q4	$2.76K	Sell	299 -143	-32%	-$1.33K	﹤0.01%	640
2022 Q3	$4K	Sell	442 -212	-32%	-$2.1K	﹤0.01%	546
2022 Q2	$5K	Buy	+654	New	+$6.24K	﹤0.01%	563
2022 Q1	–	Sell	-476	Closed	-$16K	–	1081
2021 Q4	$16K	Hold	476	–	–	﹤0.01%	505
2021 Q3	$23K	Buy	476 +430	+935%	+$19.9K	﹤0.01%	501
2021 Q2	$2K	Buy	+46	New	+$2.04K	﹤0.01%	697

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Manchester Capital Management's NEO Position: Q1 2025 in Review

Manchester Capital Management sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 142 shares — an estimated $2.34K sold.

Manchester Capital Management first reported a position in NEO in Q2 2021 and held it in 14 quarters. The position peaked at $23K in Q3 2021. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

Manchester Capital Management reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
Manchester Capital Management sold 142 NeoGenomics shares in Q1 2025, an estimated $2.34K.
Manchester Capital Management first reported a position in NeoGenomics in Q2 2021 and held it in 14 quarters.
Manchester Capital Management's NeoGenomics position peaked at $23K in Q3 2021.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on Manchester Capital Management's 13F filing for Q1 2025, filed 9 May 2025.